- Country: USA
- Summary: National Cooperative Drug/Device Discovery/Development Groups (Ncddg) for the Treatment of Mental Disorders or Alcohol Use Disorder (U19 Clinical Trial Optional)
- UST Ref No: 66199960
- Deadline: 24 Feb 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: PAR-22-144
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Tender are invited for National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders or Alcohol Use Disorder (U19 Clinical Trial Optional)
CFDA Number : 93.242 -- Mental Health Research Grants93.273 -- Alcohol Research Programs
Cost Sharing or Matching Requirement : No
Closing Date for Applications: Feb 24, 2025
Posted Date : May 06, 2022
Description: Reissue of PAR-20-119. This FOA encourages applications to advance the discovery, preclinical development, and proof of concept (PoC) testing of new, rationally based candidate agents and neurostimulation approaches to treat mental disorders, substance use disorders (SUDs) or alcohol use disorder (AUD), and to develop novel ligands and circuit-engagement devices as tools to further characterize existing or to validate new drug/device targets. Partnerships between academia and industry are strongly encouraged. This FOA supports a research program of multiple projects directed toward a specific major objective, basic theme or program goal, requiring a broadly based, multidisciplinary and often long-term approach. Projects seeking support for a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies should consider the companion U01 FOA. - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINNational Cooperative Drug/Device Discovery/Development Groups (Ncddg) for the Treatment of Mental Disorders or Alcohol Use Disorder (U19 Clinical Trial Optional) - USA Tender
The NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for National Cooperative Drug/Device Discovery/Development Groups (Ncddg) for the Treatment of Mental Disorders or Alcohol Use Disorder (U19 Clinical Trial Optional). This tender is published on USARFP under UST Ref No: 66199960 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-02-24.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
